Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
JAMA Dermatol ; 159(3): 340-342, 2023 03 01.
Article in English | MEDLINE | ID: mdl-36598777

ABSTRACT

This case report describes a woman in her 60s flesh-colored papules that were localized to the central face and a lobular downgrowth of cells with clear, expanded, faintly glassy cytoplasm.


Subject(s)
Hair Diseases , Skin Neoplasms , Humans , Skin Neoplasms/drug therapy , Immunosuppressive Agents/therapeutic use , Sirolimus/therapeutic use
2.
Nat Commun ; 10(1): 2945, 2019 07 03.
Article in English | MEDLINE | ID: mdl-31270332

ABSTRACT

Age- and sex-related alterations in gene transcription have been demonstrated, however the underlying mechanisms are unresolved. Neuroepigenetic pathways regulate gene transcription in the brain. Here, we measure in vivo expression of the epigenetic enzymes, histone deacetylases (HDACs), across healthy human aging and between sexes using [11C]Martinostat positron emission tomography (PET) neuroimaging (n = 41). Relative HDAC expression increases with age in cerebral white matter, and correlates with age-associated disruptions in white matter microstructure. A post mortem study confirmed that HDAC1 and HDAC2 paralogs are elevated in white matter tissue from elderly donors. There are also sex-specific in vivo HDAC expression differences in brain regions associated with emotion and memory, including the amygdala and hippocampus. Hippocampus and white matter HDAC expression negatively correlates with emotion regulation skills (n = 23). Age and sex are associated with HDAC expression in vivo, which could drive age- and sex-related transcriptional changes and impact human behavior.


Subject(s)
Brain/physiology , Epigenesis, Genetic , Sex Characteristics , Adamantane/analogs & derivatives , Adamantane/pharmacokinetics , Adolescent , Adult , Age Factors , Aged , Brain/diagnostic imaging , Carbon Radioisotopes/pharmacokinetics , Emotions , Female , Histone Deacetylase 1/metabolism , Histone Deacetylase 2/metabolism , Humans , Hydroxamic Acids/pharmacokinetics , Male , Middle Aged , Tissue Donors , White Matter/anatomy & histology , White Matter/diagnostic imaging , Young Adult
3.
J Clin Invest ; 129(1): 364-372, 2019 01 02.
Article in English | MEDLINE | ID: mdl-30530989

ABSTRACT

BACKGROUND: Patients with schizophrenia (SCZ) experience chronic cognitive deficits. Histone deacetylases (HDACs) are enzymes that regulate cognitive circuitry; however, the role of HDACs in cognitive disorders, including SCZ, remains unknown in humans. We previously determined that HDAC2 mRNA levels were lower in dorsolateral prefrontal cortex (DLPFC) tissue from donors with SCZ compared with controls. Here we investigated the relationship between in vivo HDAC expression and cognitive impairment in patients with SCZ and matched healthy controls using [11C]Martinostat positron emission tomography (PET). METHODS: In a case-control study, relative [11C]Martinostat uptake was compared between 14 patients with SCZ or schizoaffective disorder (SCZ/SAD) and 17 controls using hypothesis-driven region-of-interest analysis and unbiased whole brain voxel-wise approaches. Clinical measures, including the MATRICS consensus cognitive battery, were administered. RESULTS: Relative HDAC expression was lower in the DLPFC of patients with SCZ/SAD compared with controls, and HDAC expression positively correlated with cognitive performance scores across groups. Patients with SCZ/SAD also showed lower relative HDAC expression in the dorsomedial prefrontal cortex and orbitofrontal gyrus, and higher relative HDAC expression in the cerebral white matter, pons, and cerebellum compared with controls. CONCLUSIONS: These findings provide in vivo evidence of HDAC dysregulation in patients with SCZ and suggest that altered HDAC expression may impact cognitive function in humans. FUNDING: National Institute of Mental Health (NIMH), Brain and Behavior Foundation, Massachusetts General Hospital (MGH), Athinoula A. Martinos Center for Biomedical Imaging, National Institute of Biomedical Imaging and Bioengineering (NIBIB), NIH Shared Instrumentation Grant Program.


Subject(s)
Gene Expression Regulation, Enzymologic , Histone Deacetylases/biosynthesis , Neuroimaging , Positron-Emission Tomography , Prefrontal Cortex , Schizophrenia , Adult , Case-Control Studies , Female , Humans , Male , Middle Aged , Prefrontal Cortex/diagnostic imaging , Prefrontal Cortex/enzymology , Psychotic Disorders/diagnostic imaging , Psychotic Disorders/enzymology , Schizophrenia/diagnostic imaging , Schizophrenia/enzymology
4.
Sci Transl Med ; 8(351): 351ra106, 2016 08 10.
Article in English | MEDLINE | ID: mdl-27510902

ABSTRACT

Epigenetic dysfunction is implicated in many neurological and psychiatric diseases, including Alzheimer's disease and schizophrenia. Consequently, histone deacetylases (HDACs) are being aggressively pursued as therapeutic targets. However, a fundamental knowledge gap exists regarding the expression and distribution of HDACs in healthy individuals for comparison to disease states. Here, we report the first-in-human evaluation of neuroepigenetic regulation in vivo. Using positron emission tomography with [(11)C]Martinostat, an imaging probe selective for class I HDACs (isoforms 1, 2, and 3), we found that HDAC expression is higher in cortical gray matter than in white matter, with conserved regional distribution patterns within and between healthy individuals. Among gray matter regions, HDAC expression was lowest in the hippocampus and amygdala. Through biochemical profiling of postmortem human brain tissue, we confirmed that [(11)C]Martinostat selectively binds HDAC isoforms 1, 2, and 3, the HDAC subtypes most implicated in regulating neuroplasticity and cognitive function. In human stem cell-derived neural progenitor cells, pharmacologic-level doses of Martinostat induced changes in genes closely associated with synaptic plasticity, including BDNF (brain-derived neurotrophic factor) and SYP (synaptophysin), as well as genes implicated in neurodegeneration, including GRN (progranulin), at the transcript level, in concert with increased acetylation at both histone H3 lysine 9 and histone H4 lysine 12. This study quantifies HDAC expression in the living human brain and provides the foundation for gaining unprecedented in vivo epigenetic information in health and disease.


Subject(s)
Adamantane/analogs & derivatives , Histone Deacetylases/metabolism , Hydroxamic Acids/metabolism , Positron-Emission Tomography/methods , Protein Isoforms/metabolism , Adamantane/metabolism , Adult , Brain/metabolism , Brain-Derived Neurotrophic Factor/metabolism , Female , Healthy Volunteers , Humans , Hydroxamic Acids/chemistry , Intercellular Signaling Peptides and Proteins/metabolism , Male , Progranulins , Synaptophysin/metabolism , Vorinostat , Young Adult
5.
Neurosci Biobehav Rev ; 52: 56-73, 2015 May.
Article in English | MEDLINE | ID: mdl-25684726

ABSTRACT

Non-invasive positron emission tomography (PET) and single-photon emission computed tomography (SPECT) are techniques used to quantify molecular interactions, biological processes and protein concentration and distribution. In the central nervous system, these molecular imaging techniques can provide critical insights into neurotransmitter receptors and their occupancy by neurotransmitters or drugs. In recent years, there has been an increase in the number of studies that have investigated neurotransmitters in autism spectrum disorder (ASD), while earlier studies mostly focused on cerebral blood flow and glucose metabolism. The underlying and contributing mechanisms of ASD are largely undetermined and ASD diagnosis relies on the behavioral phenotype. Discovery of biochemical endophenotypes would represent a milestone in autism research that could potentially lead to ASD subtype stratification and the development of novel therapeutic drugs. This review characterizes the prior use of molecular imaging by PET and SPECT in ASD, addresses methodological challenges and highlights areas of future opportunity for contributions from molecular imaging to understand ASD pathophysiology.


Subject(s)
Autism Spectrum Disorder/diagnostic imaging , Autism Spectrum Disorder/pathology , Positron-Emission Tomography , Tomography, Emission-Computed, Single-Photon , Databases, Bibliographic , Humans , Neurotransmitter Agents/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...